Kisplyx (axitinib)

axitinib · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Kisplyx (axitinib), covering 2024-05-29 to 2024-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic Carcinoma [Phase 2]